Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations

Yijun Jia, Xuefei Li, Chao Zhao, Shengxiang Ren, Chunxia Su, Guanghui Gao, Wei Li, Fei Zhou, Jiayu Li, and Caicun Zhou
Journal   Frontiers in Oncology
Species  
Analytes Measured   PD-L1 epitope 1 , EGFR
Matrix Tested  
Year   2020
Volume   Journal Volume
Page Numbers   Journal Page Number(s)
Application   Oncology and Cancer

View Publications

Related Products

U-PLEX CAR-T Cell Exhaustion Combo 1 (human)
CD28, CTLA-4, IFN-γ, LAG3, PD-L1 (epitope 1), TIGIT, TNF-α | Human
Multiplex
U-PLEX CAR-T Cell Persistence Combo 1 (human)
CD40L (soluble), Granzyme B, IFN-γ, IL-7, IL-15, IL-18, LAG3, PD-L1 (epitope 1), TNF-α | Human
Multiplex
U-PLEX Target Cell Checkpoint Combo 1 (human)
CD276/B7-H3, GITRL/TNFSF18, PD-L1 (epitope 1), PD-L2 | Human
Multiplex
U-PLEX Human PD-L1 (epitope 1) 384-Well Assay
PD-L1 (epitope 1) | Human
Singleplex
R-PLEX Human EGFR Antibody Set
EGFR | Human
U-PLEX Human PD-L1 (epitope 1) Assay
PD-L1 (epitope 1) | Human
Singleplex
U-PLEX Human PD-L1 (epitope 1) Antibody Set
PD-L1 (epitope 1) | Human
R-PLEX Human EGFR Assay
EGFR, EGFR (soluble) | Human
Singleplex
Total EGFR (Cytoplasmic Domain) Kit
EGFR | Human
Singleplex
Browse Our Products

By Analytes
By Applications
Search
Customer Service/Orders


Scientific/Technical Support


Instrument Support


Company Headquarters